{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:40:59Z","timestamp":1791492059659,"version":"4.3.4"},"reference-count":62,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Skim Geran Penyelidikan Fundamental, Kementerian Pendidikan Tinggi Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/SS03\/UKM\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SS03\/UKM\/02\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Skim Geran Penyelidikan Fundamental, Kementerian Pendidikan Tinggi Malaysia","doi-asserted-by":"publisher","award":["GP-2021-K017963"],"award-info":[{"award-number":["GP-2021-K017963"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National University of Malaysia","award":["FRGS\/1\/2021\/SS03\/UKM\/02\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SS03\/UKM\/02\/1"]}]},{"name":"National University of Malaysia","award":["GP-2021-K017963"],"award-info":[{"award-number":["GP-2021-K017963"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Complex anatomy surrounding the oropharynx makes proton therapy (PT), especially intensity-modulated PT (IMPT), a potentially attractive option due to its ability to reduce the volume of irradiated healthy tissues. Dosimetric improvement may not translate to clinically relevant benefits. As outcome data are emerging, we aimed to evaluate the evidence of the quality of life (QOL) and patient-reported outcomes (PROs) following PT for oropharyngeal carcinoma (OC). Materials and Methods: We searched PubMed and Scopus electronic databases (date: 15 February 2023) to identify original studies on QOL and PROs following PT for OC. We employed a fluid strategy in the search strategy by tracking citations of the initially selected studies. Reports were extracted for information on demographics, main results, and clinical and dose factor correlates. Quality assessment was performed using the NIH\u2019s Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. The PRISMA guidelines were followed in the preparation of this report. Results: Seven reports were selected, including one from a recently published paper captured from citation tracking. Five compared PT and photon-based therapy, although none were randomized controlled trials. Most endpoints with significant differences favored PT, including xerostomia, cough, need for nutritional supplements, dysgeusia, food taste, appetite, and general symptoms. However, some endpoints favored photon-based therapy (sexual symptoms) or showed no significant difference (e.g., fatigue, pain, sleep, mouth sores). The PROs and QOL improve following PT but do not appear to return to baseline. Conclusion: Evidence suggests that PT causes less QOL and PRO deterioration than photon-based therapy. Biases due to the non-randomized study design remain obstacles to a firm conclusion. Whether or not PT is cost-effective should be the subject of further investigation.<\/jats:p>","DOI":"10.3390\/cancers15082252","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T02:08:11Z","timestamp":1681265291000},"page":"2252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quality of Life and Patient-Reported Outcomes Following Proton Therapy for Oropharyngeal Carcinoma: A Systematic Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2736-6489","authenticated-orcid":false,"given":"Noorazrul","family":"Yahya","sequence":"first","affiliation":[{"name":"Diagnostic Imaging and Radiotherapy, Center for Diagnostic, Therapeutic and Investigative Studies (CODTIS), Faculty of Health Sciences, National University of Malaysia, Jalan Raja Muda Aziz, Kuala Lumpur 50300, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6769-0603","authenticated-orcid":false,"given":"Hanani Abdul","family":"Manan","sequence":"additional","affiliation":[{"name":"Functional Image Processing Laboratory, Department of Radiology, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Kuala Lumpur 56000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2017.03.006","article-title":"Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients","volume":"78","author":"Gronhoj","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.radonc.2018.06.014","article-title":"Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma","volume":"128","author":"Dixon","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2016.05.011","article-title":"Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy","volume":"96","author":"Sapir","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.oraloncology.2019.05.016","article-title":"Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment","volume":"95","author":"Windon","year":"2019","journal-title":"Oral Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/0284186X.2017.1324209","article-title":"Parotid gland mean dose as a xerostomia predictor in low-dose domains","volume":"56","author":"Gabrys","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1038\/s41598-019-40228-y","article-title":"Dose\/Volume histogram patterns in Salivary Gland subvolumes influence xerostomia injury and recovery","volume":"9","author":"Han","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.anl.2018.01.010","article-title":"Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer","volume":"45","author":"Kawamoto","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00066-019-01572-0","article-title":"Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma","volume":"196","author":"Mogadas","year":"2020","journal-title":"Strahlenther Onkol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/hed.25594","article-title":"Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma","volume":"41","author":"Cui","year":"2019","journal-title":"Head Neck"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.canrad.2019.05.015","article-title":"Proton therapy for head and neck squamous cell carcinomas: From physics to clinic","volume":"23","author":"Beddok","year":"2019","journal-title":"Cancer Radiother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2011.05.028","article-title":"Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer","volume":"101","author":"Simone","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.meddos.2013.05.001","article-title":"Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: A treatment planning comparison","volume":"38","author":"Kandula","year":"2013","journal-title":"Med. Dosim."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yahya, N., Mohamad Salleh, S.A., Mohd Nasir, N.F., and Abdul Manan, H. (2023). Toxicity profile of patients treated with proton and carbon-ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta-analysis. Asia Pac. J. Clin. Oncol.","DOI":"10.1111\/ajco.13915"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.meddos.2016.09.004","article-title":"Pencil beam scanning proton therapy vs rotational arc radiation therapy: A treatment planning comparison for postoperative oropharyngeal cancer","volume":"42","author":"Apinorasethkul","year":"2017","journal-title":"Med. Dosim."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/0284186X.2020.1714720","article-title":"Radiation dose-painting with protons vs. photons for head-and-neck cancer","volume":"59","author":"Smulders","year":"2020","journal-title":"Acta Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2018.11.015","article-title":"Intensity modulated proton therapy (IMPT)\u2014The future of IMRT for head and neck cancer","volume":"88","author":"Moreno","year":"2019","journal-title":"Oral Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijrobp.2017.09.043","article-title":"Efficient Interplay Effect Mitigation for Proton Pencil Beam Scanning by Spot-Adapted Layered Repainting Evenly Spread out Over the Full Breathing Cycle","volume":"100","author":"Poulsen","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/acm2.13183","article-title":"Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy","volume":"22","author":"Rana","year":"2021","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1002\/mp.13094","article-title":"4D robust optimization including uncertainties in time structures can reduce the interplay effect in proton pencil beam scanning radiation therapy","volume":"45","author":"Engwall","year":"2018","journal-title":"Med. Phys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.radonc.2020.07.055","article-title":"Evaluation of interplay and organ motion effects by means of 4D dose reconstruction and accumulation","volume":"150","author":"Meijers","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2020.03.006","article-title":"Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges","volume":"147","author":"Beddok","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1088\/0031-9155\/52\/10\/009","article-title":"Accounting for range uncertainties in the optimization of intensity modulated proton therapy","volume":"52","author":"Unkelbach","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"015004","DOI":"10.1088\/1361-6560\/aaf30b","article-title":"Online adaption approaches for intensity modulated proton therapy for head and neck patients based on cone beam CTs and Monte Carlo simulations","volume":"64","author":"Botas","year":"2018","journal-title":"Phys. Med. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/0284186X.2022.2081931","article-title":"Assessment of gene expressions from squamous cell carcinoma of the head and neck to predict radiochemotherapy-related xerostomia and dysphagia","volume":"61","author":"Yahya","year":"2022","journal-title":"Acta Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/hed.25631","article-title":"Systematic review and meta-analysis of the impact of dosimetry to dysphagia and aspiration related structures","volume":"41","author":"Charters","year":"2019","journal-title":"Head Neck"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"22TR01","DOI":"10.1088\/1361-6560\/ac344f","article-title":"Adaptive proton therapy","volume":"66","author":"Paganetti","year":"2021","journal-title":"Phys. Med. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review","volume":"110","author":"Verma","year":"2018","journal-title":"J. Nat. Cancer Inst."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"ref_29","unstructured":"National Heart Lung, and Blood Institute (2018). Study Quality Assessment Tools."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e13329","DOI":"10.1111\/ecc.13329","article-title":"Diffusion tensor imaging indices to predict cognitive changes following adult radiotherapy","volume":"30","author":"Yahya","year":"2021","journal-title":"Eur. J. Cancer Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canrad.2020.07.008","article-title":"MRI-based brain structural changes following radiotherapy of Nasopharyngeal Carcinoma: A systematic review","volume":"25","author":"Voon","year":"2021","journal-title":"Cancer Radiother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer\u2014A case matched analysis","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2020.03.010","article-title":"Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer","volume":"147","author":"Manzar","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00032.1","article-title":"Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer","volume":"5","author":"Sharma","year":"2018","journal-title":"Int. J. Part Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.02.044","article-title":"Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes","volume":"95","author":"Sio","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2019.07.012","article-title":"Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy","volume":"142","author":"Bagley","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2020.04.021","article-title":"Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer","volume":"148","author":"Grant","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2021.03.036","article-title":"Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia","volume":"160","author":"Cao","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hed.23127","article-title":"Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy\u2014Update of the EORTC QLQ-H&N35, Phase, I","volume":"35","author":"Singer","year":"2013","journal-title":"Head Neck"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1368-8375(00)00063-4","article-title":"Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy","volume":"37","author":"Henson","year":"2001","journal-title":"Oral Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2010.05.004","article-title":"The Groningen Radiotherapy-Induced Xerostomia questionnaire: Development and validation of a new questionnaire","volume":"97","author":"Beetz","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.meddos.2016.01.002","article-title":"Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis","volume":"41","author":"Holliday","year":"2016","journal-title":"Med. Dosim."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radonc.2021.12.004","article-title":"Current practice in proton therapy delivery in adult cancer patients across Europe","volume":"167","author":"Tambas","year":"2022","journal-title":"Radiother. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2018.12.055","article-title":"A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer","volume":"104","author":"Rwigema","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.radonc.2017.05.006","article-title":"Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer","volume":"123","author":"Zhang","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2016.02.021","article-title":"Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma","volume":"95","author":"Gunn","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ijrobp.2010.05.012","article-title":"Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer","volume":"79","author":"Lomax","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.21873\/invivo.12894","article-title":"Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers","volume":"36","author":"Rades","year":"2022","journal-title":"In Vivo"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Megee, F., Gough, K., Frowen, J., Dixon, B., Magarey, M., Wiesenfeld, D., and Ramakrishnan, A. (2023). Predictors of distress associated with altered appearance and function in people treated surgically for oral cancers: A cross-sectional study. Int. J. Oral Maxillofac. Surg.","DOI":"10.1016\/j.ijom.2023.01.006"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lysik, D., Niemirowicz-Laskowska, K., Bucki, R., Tokajuk, G., and Mystkowska, J. (2019). Artificial Saliva: Challenges and Future Perspectives for the Treatment of Xerostomia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133199"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ctro.2019.10.007","article-title":"A systematic review of health economic evaluations of proton beam therapy for adult cancer: Appraising methodology and quality","volume":"20","author":"Jones","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ctro.2022.11.010","article-title":"TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer","volume":"38","author":"Thomson","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ijrobp.2018.04.018","article-title":"Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma","volume":"101","author":"Sher","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2015.04.031","article-title":"Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis","volume":"92","author":"Jakobi","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/0284186X.2017.1355113","article-title":"(.G.; Breedveld, S.; Arts, T.; Astreinidou, E.; De Jong, M.A.; Granton, P.V.; Petit, S.F.; Hoogeman, M.S. Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy","volume":"56","author":"Bijman","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Yahya, N., Sukiman, N.K., Suhaimi, N.A., Azmi, N.A., and Manan, H.A. (2019). How many roads must a Malaysian walk down? Mapping the accessibility of radiotherapy facilities in Malaysia. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213583"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1111\/ajco.12831","article-title":"Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions","volume":"14","author":"Yahya","year":"2018","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s00520-020-05808-z","article-title":"Neurocognitive impairment following proton therapy for paediatric brain tumour: A systematic review of post-therapy assessments","volume":"29","author":"Yahya","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3109\/0284186X.2011.582513","article-title":"Emerging technologies in proton therapy","volume":"50","author":"Schippers","year":"2011","journal-title":"Acta Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2019.04.032","article-title":"The first prototype of spot-scanning proton arc treatment delivery","volume":"137","author":"Li","year":"2019","journal-title":"Radiother. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/8\/2252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:14:23Z","timestamp":1760123663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/8\/2252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["cancers15082252"],"URL":"https:\/\/doi.org\/10.3390\/cancers15082252","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.04.20226175","asserted-by":"object"}]},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]}}}